Edition:
United States

ICAD Inc (ICAD.OQ)

ICAD.OQ on NASDAQ Stock Exchange Capital Market

2.99USD
21 Sep 2018
Change (% chg)

$0.14 (+4.91%)
Prev Close
$2.85
Open
$2.85
Day's High
$2.99
Day's Low
$2.81
Volume
28,202
Avg. Vol
8,295
52-wk High
$4.89
52-wk Low
$2.81

Latest Key Developments (Source: Significant Developments)

Icad Inc says ‍On March 22, Co Executed First Loan Modification Agreement To Its Aug 7, 2017 Loan and Security Agreement ​
Friday, 23 Mar 2018 12:36pm EDT 

March 23 (Reuters) - Icad Inc ::ICAD INC - ‍ON MARCH 22, CO EXECUTED FIRST LOAN MODIFICATION AGREEMENT TO ITS AUG 7, 2017 LOAN, SECURITY AGREEMENT WITH SILICON VALLEY BANK - SEC FILING ​.ICAD INC - ‍AMENDMENT EXTENDED DATE TO DRAW SECOND ADVANCE UNDER LOAN AGREEMENT FROM JULY 30, 2018 TO JUNE 30, 2019​.ICAD INC - ‍AMENDMENT EXTENDED MATURITY DATE OF SECOND ADVANCE LOAN FROM AUGUST 7, 2021 TO MARCH 1, 2022​.ICAD INC - ‍AMENDMENT INCREASED FINAL PAYMENT FEE FROM 7% TO 8% OF ORIGINAL PRINCIPAL AMOUNT OF LOANS ADVANCED UNDER LOAN AGREEMENT​.  Full Article

Icad Q4 Gaap Loss Per Share $0.26
Thursday, 22 Mar 2018 04:01pm EDT 

March 22 (Reuters) - Icad Inc ::ICAD REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS.Q4 GAAP LOSS PER SHARE $0.26.Q4 REVENUE ROSE 14 PERCENT TO $7.9 MILLION.  Full Article

iCAD Expects To Reduce About 18 Pct Of Workforce Across Skin Subscription Business
Friday, 5 Jan 2018 02:08pm EST 

Jan 5 (Reuters) - Icad Inc ::ICAD INC SAYS CO EXPECTS TO REDUCE HEADCOUNT ACROSS SKIN SUBSCRIPTION BUSINESS BY ABOUT 21 EMPLOYEES OR 18% OF THE WORKFORCE- SEC FILING.ICAD INC SAYS ON JAN 4, CO ADOPTED A PLAN TO DISCONTINUE OFFERING RADIATION THERAPY PROFESSIONAL SERVICES TO PRACTICES.  Full Article

ICAD reports Q3 GAAP loss per share $0.42
Wednesday, 8 Nov 2017 04:01pm EST 

Nov 8 (Reuters) - ICAD Inc ::ICAD reports third quarter 2017 financial results.Q3 GAAP loss per share $0.42.Q3 revenue rose 17 percent to $7.0 million.  Full Article

ICAD Inc ‍announces approval of Xoft Axxent balloon applicators by China FDA
Wednesday, 30 Aug 2017 08:00am EDT 

Aug 30 (Reuters) - ICAD Inc :ICAD Inc - ‍announces approval of Xoft Axxent balloon applicators by China Food & Drug Administration for treatment of early-stage breast cancer​.  Full Article

ICAD reports Q2 loss per share $0.16
Tuesday, 8 Aug 2017 04:01pm EDT 

Aug 9 (Reuters) - iCAD Inc -:iCAD reports second quarter 2017 financial results and announces $13 million credit facility with silicon valley bank.Q2 gaap loss per share $0.16.Q2 revenue fell 13 percent to $6.4 million.  Full Article

Icad Q1 revenue rose 12.5 percent to $6.8 million
Tuesday, 2 May 2017 04:01pm EDT 

May 2 (Reuters) - Icad Inc :Icad reports first-quarter 2017 financial results.Q1 revenue rose 12.5 percent to $6.8 million.Q1 loss per share $0.03.Q1 adjusted non-GAAP loss per share $0.18.  Full Article

ICAD says receives FDA approval for PowerLook Tomo Detection
Monday, 27 Mar 2017 08:00am EDT 

ICAD Inc :ICAD receives FDA approval for PowerLook Tomo Detection.  Full Article

Icad Q4 adjusted non-gaap loss per share $0.20
Wednesday, 8 Mar 2017 04:01pm EST 

Icad Inc : Icad reports fourth quarter and full year 2016 financial results . Q4 revenue fell 9 percent to $6.9 million . Q4 adjusted non-gaap loss per share $0.20 .Q4 loss per share $0.20.  Full Article

Icad says entered into asset purchase agreement with Invivo Corp- SEC filing
Thursday, 22 Dec 2016 02:36pm EST 

Icad Inc - : Icad - On Dec 16, 2016, co entered into an asset purchase agreement between company and Invivo Corporation - SEC filing . Icad - Purchase agreement provides for a purchase price for assets of $3.2 million less a holdback reserve amount of $350,000 .Icad Inc - If closing of agreement does not occur on or before February 15, 2017, either party has right to terminate.  Full Article

BRIEF-iCad Reports Q1 GAAP Loss Per Share $0.20

* Q1 REVENUE FELL 7 PERCENT TO $6.3 MILLION Source text for Eikon: Further company coverage: